F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval

https://ift.tt/wEcZxH agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.

from NYT > Top Stories https://ift.tt/3yLVoCx